2,3-Dihydrobenzo[b][1,4]dioxine-2-carbothioamide, 98%, 1g

Morpholin-4-yl(phenyl)acetonitrile, 97.0%, 5g

4-Nitrophenyl 2-fluoropropanoate, 97%, 100mg

Methyl 1-(aminomethyl)cycloheptane-1-carboxylate, 95%, 1g

((2R,6R)-6-Methylmorpholin-2-yl)methanol hydrochloride, 98%, 500mg

1-((4-Nitrophenyl)sulfonyl)piperidine, 95.0%, 5g

Quinoxaline-6-carbaldehyde, 95.0%, 25g

1,3-dihydro-2,1-benzoxaborole-1,5-diol, 95.0%, 5g

2-(3,4-Dichloro-phenyl)-pyrrolidine hydrochloride, 1g

DL-Lysine hydrochloride, min. 98%, for biochemistry, 5 g, plastic packaging.

Cyclobutylboronic acid, 95.0%, 10g

(Z)-4-(2-METHOXYETHYLAMINO)-4-OXOBUT-2-ENOIC ACID, 95.0%, 250mg

3-Methyl-5-nitrobenzaldehyde, 95.0%, 1g